Viewing Study NCT07145918


Ignite Creation Date: 2025-12-25 @ 4:30 AM
Ignite Modification Date: 2025-12-26 @ 3:32 AM
Study NCT ID: NCT07145918
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2025-08-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module